Skip to main content
Journal cover image

ACR Appropriateness Criteria® Transgender Breast Cancer Screening.

Publication ,  Journal Article
Expert Panel on Breast Imaging, ; Brown, A; Lourenco, AP; Niell, BL; Cronin, B; Dibble, EH; DiNome, ML; Goel, MS; Hansen, J; Heller, SL; Moy, L ...
Published in: J Am Coll Radiol
November 2021

Breast cancer screening recommendations for transgender and gender nonconforming individuals are based on the sex assigned at birth, risk factors, and use of exogenous hormones. Insufficient evidence exists to determine whether transgender people undergoing hormone therapy have an overall lower, average, or higher risk of developing breast cancer compared to birth-sex controls. Furthermore, there are no longitudinal studies evaluating the efficacy of breast cancer screening in the transgender population. In the absence of definitive data, current evidence is based on data extrapolated from cisgender studies and a limited number of cohort studies and case reports published on the transgender community. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Radiol

DOI

EISSN

1558-349X

Publication Date

November 2021

Volume

18

Issue

11S

Start / End Page

S502 / S515

Location

United States

Related Subject Headings

  • United States
  • Transgender Persons
  • Societies, Medical
  • Nuclear Medicine & Medical Imaging
  • Infant, Newborn
  • Humans
  • Female
  • Early Detection of Cancer
  • Diagnostic Imaging
  • Breast Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Expert Panel on Breast Imaging, ., Brown, A., Lourenco, A. P., Niell, B. L., Cronin, B., Dibble, E. H., … Moy, L. (2021). ACR Appropriateness Criteria® Transgender Breast Cancer Screening. J Am Coll Radiol, 18(11S), S502–S515. https://doi.org/10.1016/j.jacr.2021.09.005
Expert Panel on Breast Imaging, Linda, Ann Brown, Ana P. Lourenco, Bethany L. Niell, Beth Cronin, Elizabeth H. Dibble, Maggie L. DiNome, et al. “ACR Appropriateness Criteria® Transgender Breast Cancer Screening.J Am Coll Radiol 18, no. 11S (November 2021): S502–15. https://doi.org/10.1016/j.jacr.2021.09.005.
Expert Panel on Breast Imaging, Brown A, Lourenco AP, Niell BL, Cronin B, Dibble EH, et al. ACR Appropriateness Criteria® Transgender Breast Cancer Screening. J Am Coll Radiol. 2021 Nov;18(11S):S502–15.
Expert Panel on Breast Imaging, Linda, et al. “ACR Appropriateness Criteria® Transgender Breast Cancer Screening.J Am Coll Radiol, vol. 18, no. 11S, Nov. 2021, pp. S502–15. Pubmed, doi:10.1016/j.jacr.2021.09.005.
Expert Panel on Breast Imaging, Brown A, Lourenco AP, Niell BL, Cronin B, Dibble EH, DiNome ML, Goel MS, Hansen J, Heller SL, Jochelson MS, Karrington B, Klein KA, Mehta TS, Newell MS, Schechter L, Stuckey AR, Swain ME, Tseng J, Tuscano DS, Moy L. ACR Appropriateness Criteria® Transgender Breast Cancer Screening. J Am Coll Radiol. 2021 Nov;18(11S):S502–S515.
Journal cover image

Published In

J Am Coll Radiol

DOI

EISSN

1558-349X

Publication Date

November 2021

Volume

18

Issue

11S

Start / End Page

S502 / S515

Location

United States

Related Subject Headings

  • United States
  • Transgender Persons
  • Societies, Medical
  • Nuclear Medicine & Medical Imaging
  • Infant, Newborn
  • Humans
  • Female
  • Early Detection of Cancer
  • Diagnostic Imaging
  • Breast Neoplasms